Health

  • August 31, 2026

    Nuvo's $9.75M D&O Deal Ends US-Israel Bankruptcy Clash

    Bankrupt pregnancy-technology firm Nuvo Group and an Israeli court-appointed trustee tasked with liquidating it reached an agreement that resolves their cross-border disputes by using a $9.75 million settlement payment from insurers of former executives.

  • August 31, 2026

    Hospital Ex-Exec Pleads Not Guilty To $239M Testing Fraud

    A former Chicago hospital executive who stopped fighting extradition to face fraud, money laundering, embezzlement and several other U.S. criminal charges pled not guilty Monday to prosecutors' accusation that he stole more than $239 million in a COVID-19 testing fraud scheme.

  • August 31, 2026

    Holland & Knight Adds Duo From McDermott Lobbying Arm

    Holland & Knight LLP has grown its federal government affairs practice in the nation's capital with the addition of an attorney and senior director from McDermott+, the now-closed consulting and lobbying affiliate of McDermott Will & Schulte, the firm said Monday.

  • August 31, 2026

    Mead Johnson Prevails In 1st Infant Formula MDL Trial

    An Illinois federal jury sided with Mead Johnson on Monday in a lawsuit claiming its infant formula caused a premature baby boy to develop a fatal intestinal disease, rejecting his mother's claims that the company should be held liable for making a defective product and failing to adequately warn doctors of the risks associated with it.

  • August 31, 2026

    Anthem Owes $854K For No Surprises Act Awards, Court Told

    An air ambulance company has told a Virginia federal court that two Anthem Blue Cross and Blue Shield affiliates and nearly two dozen plan sponsors violated the No Surprises Act by failing to pay more than $854,000 in binding arbitration awards stemming from the provision of out-of-network emergency services.

  • August 31, 2026

    Ropes-Steered Lilly To Buy Goodwin-Led Merida For $2.9B

    Eli Lilly and Co., advised by Ropes & Gray LLP, said Monday that it has agreed to pay up to $2.875 billion in cash to purchase autoimmune- and allergic disease-focused biotech Merida Biosciences Inc., which is being advised by Goodwin Procter LLP.

  • August 31, 2026

    8th Circ. Backs Social Security Disability Benefits Denial

    The Eighth Circuit affirmed the dismissal of a worker's suit challenging the Social Security Administration's denial of her bid for disability benefits, finding it was fair game for an administrative law judge to credit an agency doctor's opinion that she was more physically capable than she had claimed.

  • August 28, 2026

    Mead Johnson, Mom Clash On Formula Risks In Trial Closing

    An Illinois federal jury is set to begin deliberating Monday on a mother's claims that Mead Johnson is liable for her infant son's death, with attorneys making closing remarks Friday in the first test case to be tried among more than 800 consolidated lawsuits linking a deadly bowel condition to premature baby formula.

  • August 28, 2026

    Ind. Panel Affirms $3.5M Med Mal Verdict Over Amputated Leg

    An Indiana appellate panel on Friday upheld a $3.5 million verdict — later reduced to $1.25 million — in a suit accusing a doctor of negligently causing a patient's leg amputation, rejecting the doctor's argument that an alleged juror-tampering incident led to an unfair trial.

  • August 28, 2026

    Calif. Panel Upholds Win For Dentist In Fatal Trip-And-Fall Suit

    The deletion of surveillance footage showing a woman's fatal trip and fall outside a California dentist's office was not spoliation, a state appeals court ruled Friday, calling the erasure unintentional while upholding a lower court's order ending the wrongful death lawsuit.

  • August 28, 2026

    Walmart Pays $50M To End DOJ's Suit Over Opioid Crisis

    Walmart has agreed to pay $50 million to settle the U.S. Department of Justice's nearly 6-year-old lawsuit in Delaware federal court alleging the big-box retailer helped spur the nationwide opioid crisis by unlawfully dispensing controlled drugs from its pharmacies, the department announced Friday.

  • August 28, 2026

    2nd Circ. Revives FCA Overpayment Suit Against Pharmacy

    A Second Circuit panel on Friday undid a whistleblower's loss on False Claims Act allegations that AmerisourceBergen Corp.'s pharmacy business owes the government money for overpayments from federal healthcare programs for drug purchases and other services.

  • August 28, 2026

    Ex-Eli Lilly Rep Can't File Whistleblower Claims In NJ

    A New Jersey federal judge on Friday dismissed a former Eli Lilly sales manager's suit alleging she was fired after objecting to pressure to promote off-label use of the diabetes drug Mounjaro, finding that the court lacked personal jurisdiction over the Indiana‑based drugmaker.

  • August 28, 2026

    Don't Miss It: Kirkland, Latham Steer Latest Hot Deals

    A lot can happen in the world of mergers and acquisitions and equity fundraising over the course of a couple of weeks, and it's difficult to keep up with all the deals.

  • August 28, 2026

    Mylan, Lannett, Others Can't Split Up Humana Generics Trial

    A Pennsylvania federal judge refused Friday to let Mylan, Lannett and other generic-drug makers split up Humana's looming price-fixing trial between liability and damages, preferring a single go in front of a single jury for the first trial in the sprawling multidistrict litigation.

  • August 28, 2026

    NM Court Trims County's Bid For Inmate Settlement Coverage

    A New Mexico federal court rejected much of a county's suit against a mental health provider and its insurer in a dispute over whether they broke their indemnification duties by settling correctional facility inmate suits without also settling the county's claims.

  • August 28, 2026

    NJ Says TikTok Is Withholding Key Child Usage Data

    New Jersey urged a state judge to force TikTok to hand over detailed user engagement data the state said was essential in proving that the platform's design harmed children, accusing the company of months of evasive answers, shifting explanations and contradictory statements about whether the information even exists.

  • August 28, 2026

    AI-Bolstered Drug Co. Hits Ch. 11 With $105M Debt

    A company that uses artificial intelligence to explore new uses for existing drugs entered bankruptcy in Delaware with over $104 million in debt and a stalking horse bidder.

  • August 28, 2026

    Doctor Shorted Practice Co-Owner On Distributions, Suit Says

    A Colorado ophthalmologist failed to pay the co-owner of his practice the full distribution amounts owed to that physician while overpaying himself, according to a lawsuit filed in state court.

  • August 28, 2026

    McDermott Closing Health Policy Shop In DC

    McDermott Will & Schulte is closing its healthcare lobbying and consulting shop after a dozen years in business.

  • August 28, 2026

    Medical Marijuana Industry Grapples With DEA's New Role

    After years of allowing the state-sanctioned medical marijuana industry to operate without interference, the U.S. Drug Enforcement Administration is stepping in to regulate a drug it once treated exclusively as contraband, but attorneys and regulators say the cannabis industry's interactions with the agency are off to a rocky start.

  • August 28, 2026

    Fla. Says PBMs Fixed Prices For Prescription Drugs

    Florida's attorney general on Thursday sued two competing pharmacy benefit managers for allegedly colluding to fix prescription drug reimbursement rates to pharmacies, which the state said threatens Floridians' access to affordable medications.

  • August 28, 2026

    Minnesota Urges Justices To Reject Foster Parents' ICWA Bid

    The Minnesota Attorney General's Office said two foster parents' challenge to the Indian Child Welfare Act is far from over, because even if they could clear a jurisdictional bar, the Supreme Court will likely remand the dispute and leave the couple's equal protection question to be litigated another day.

  • August 28, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen shoe brand Crocs bring an appeal against the chief executive of the U.K.'s Intellectual Property Office, singer Alanis Morissette sued by the former head of operations at Live Nation Israel and the son of convicted fraudster Guo Wengui file an appeal against the Chapter 11 trustee controlling his father's bankruptcy estate. 

  • August 28, 2026

    4 Arguments For Benefits Attys To Watch In September

    The Fifth Circuit will weigh Louisiana's bid to block telehealth access to the abortion drug mifepristone, while the Fourth Circuit will hear Lockheed Martin's challenge to a trial court decision that kept a pension de-risking suit alive. Here's a look at these and other argument sessions that should be on benefits attorneys' radar next month.

Expert Analysis

  • Series

    Teaching SEC Investigations Makes Me A Better Lawyer

    Author Photo

    Instructing a law school course on U.S. Securities and Exchange Commission investigations has made me a more thoughtful, deliberate practitioner because it requires me to continually reassess and challenge what I know about securities law enforcement, how I know it and how best to explain it, says David Chase at Miami Law.

  • Noncompete Laws Show States Focusing On Bans, Healthcare

    Author Photo

    The first half of 2026 confirms that state legislatures are driving the most consequential changes in noncompete law, including a few state bans and several healthcare-specific laws, making a one-size-fits-all approach increasingly untenable for multistate employers, say attorneys at Faegre Drinker.

  • Where The Justices Aligned In Appellate Authority Ruling

    Author Photo

    The real story of the U.S. Supreme Court’s recent ruling in T.M. v. University of Maryland Medical System Corp., finding that a doctrine designed to curtail duplicative litigation prevents federal district courts from reviewing state court decisions, is in how the justices together revisited an obscure, century-old jurisdictional doctrine, says Alex Dimitrief at Zeughauser Group.

  • Rare DOJ Military Bias Suit Shows Peril Of Co. Admissions

    Author Photo

    Although the government rarely litigates Uniformed Services Employment and Reemployment Rights Act claims against private employers, Opara v. UV Memory Care demonstrates that it will do so when an employer's own admissions build the case, potentially resulting in significant compliance obligations and long-term consequences, says Bradford Kelley at Littler.

  • Series

    Judges On AI: Examining Administrative, Organizational Uses

    Author Photo

    U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.

  • USPTO-Fed. Circ. Split Complicates Machine Learning Patents

    Author Photo

    The wide chasm between the USPTO's and the Federal Circuit's approach to eligibility for machine learning patents means that patent drafters must avoid functional claiming and specifications if they hope to avoid invalidation of a machine learning patent at the appellate court, says attorney Michael Kiklis.

  • Class Actions At The Circuit Courts: July Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses four recent rulings involving wage and hour allegations, medical care for incarcerated individuals, oil and gas royalty payments, and nuisance claims.

  • AG Watch: Ohio AG Joins State Antitrust Enforcement Trend

    Author Photo

    Amid the recent reprioritization in the federal government's competition enforcement agenda, two recent cases provide critical insight into how the Ohio attorney general will proceed in the relatively unprecedented trend of state attorneys general aggressively pursuing antitrust matters, say attorneys at BakerHostetler.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • Mass. UHC Fraud Suit Signals States' Medicaid FCA Push

    Author Photo

    Massachusetts' recently filed False Claims Act suit alleging UnitedHealthcare misrepresented the health status of enrollees in a Medicaid senior care organization plan it managed pushes forward a new phase of state-level scrutiny of managed care data and Medicaid payment mechanisms, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwendolyn Stamper at Vogel Slade.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

  • FDA Draft Guidance Maps Payor Strategy For Psychedelics

    Author Photo

    Recently revised guidance from the U.S. Food and Drug Administration will operationalize a framework permitting drug developers to share product information with insurance companies, giving psychedelic therapeutics developers a road map for building a successful payor infrastructure before approval, says Kimberly Chew at Husch Blackwell.

  • Trade Secret Practice Tips From The 1st Half Of 2026

    Author Photo

    Intellectual property attorneys should consider what several significant developments in 2026 thus far mean for how they protect, litigate and value trade secrets, focusing on new state noncompete bans, cases scrutinizing how plaintiffs identify trade secrets and federal rulings on damages doctrines, say attorneys at Faegre Drinker.

  • Preparing For Next Congress With Eye On Investigation Risk

    Author Photo

    Rod Rosenstein, Brian Whisler and Bruce Linskens at Baker McKenzie offer advice for organizations seeking to build a proactive response plan to potential congressional oversight as the election looms.

  • Opinion

    Denying Emergency Abortion Care Is A Liability Oversight

    Author Photo

    Health systems in states with abortion bans should consider that refusing to provide emergency abortion care carries greater legal risk than the risk of prosecution under post-Dobbs laws for providing treatment, say Kimberly Chernoby at FemInEM and Rachel Rebouché at the University of Texas, Austin School of Law.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.